Cognition Therapeutics, Inc.

CGTX · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$34-$26-$21-$12
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$4$4$4$5
Change in WC$1$5-$1$3
Other Non-Cash$0$0$0-$0
Operating Cash Flow-$28-$16-$19-$4
Investing Activities
PP&E Inv.-$0-$0-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$0-$0-$0-$0
Financing Activities
Debt Repay.-$1-$1-$1-$0
Stock Issued$24$5$5$44
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$0$0$2$9
Financing Cash Flow$24$5$6$53
Forex Effect$0$0-$0-$0
Net Chg. in Cash-$5-$12-$13$50
Supplemental Information
Beg. Cash$30$42$55$5
End Cash$25$30$42$55
Free Cash Flow-$28-$16-$19-$4